Opportunities and Challenges of Generic Pre-Exposure Prophylaxis Drugs for HIV

Antiretroviral pre-exposure prophylaxis (PrEP) is protective against HIV. Low utilization rates amongst HIV vulnerable populations are due in part to the high cost of PrEP. Generic PrEP offers the potential to improve health at significantly reduced costs. In this study, we examine early utilization...

Descripción completa

Detalles Bibliográficos
Autores principales: Ballreich, Jeromie, Levengood, Timothy, Conti, Rena M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Independent Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9341204/
https://www.ncbi.nlm.nih.gov/pubmed/35902088
http://dx.doi.org/10.1017/jme.2022.33

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9341204/
https://www.ncbi.nlm.nih.gov/pubmed/35902088
http://dx.doi.org/10.1017/jme.2022.33

Ejemplares similares